Your browser doesn't support javascript.
loading
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.
Metrebian, N; Weaver, T; Pilling, S; Hellier, J; Byford, S; Shearer, J; Mitcheson, L; Astbury, M; Bijral, P; Bogdan, N; Bowden-Jones, O; Day, E; Dunn, J; Finch, E; Forshall, S; Glasper, A; Morse, G; Akhtar, S; Bajaria, J; Bennett, C; Bishop, E; Charles, V; Davey, C; Desai, R; Goodfellow, C; Haque, F; Little, N; McKechnie, H; Morris, J; Mosler, F; Mutz, J; Pauli, R; Poovendran, D; Slater, E; Strang, J.
Afiliação
  • Metrebian N; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK. Electronic address: nicola.metrebian@kcl.ac.uk.
  • Weaver T; Imperial College London, London, UK; Middlesex University, London, UK.
  • Pilling S; University College London, London, UK.
  • Hellier J; King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Byford S; King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Shearer J; King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Mitcheson L; South London and Maudsley NHS Foundation Trust, London, UK.
  • Astbury M; Dudley & Walsall Mental Health Partnership Trust, Dudley, UK.
  • Bijral P; Change, Grow, Live Charity, Management Offices, London, UK.
  • Bogdan N; South Essex Partnership NHS Foundation Trust, Essex, UK.
  • Bowden-Jones O; Central and North West London NHS Foundation Trust, London, UK.
  • Day E; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK; Birmingham & Solihull Mental Health NHS Foundation Trust, Birmingham, UK.
  • Dunn J; Camden & Islington NHS Foundation Trust, London, UK.
  • Finch E; South London and Maudsley NHS Foundation Trust, London, UK.
  • Forshall S; Avon & Wiltshire Mental Health Partnership NHS Trust, Bristol, UK.
  • Glasper A; Sussex Partnership NHS Foundation Trust, Brighton, UK.
  • Morse G; Turning Point Charity, London, UK.
  • Akhtar S; Birmingham & Solihull Mental Health NHS Foundation Trust, Birmingham, UK.
  • Bajaria J; South Essex Partnership NHS Foundation Trust, Essex, UK.
  • Bennett C; Birmingham & Solihull Mental Health NHS Foundation Trust, Birmingham, UK.
  • Bishop E; University College London, London, UK.
  • Charles V; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Davey C; Avon & Wiltshire Mental Health Partnership NHS Trust, Bristol, UK.
  • Desai R; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Goodfellow C; University College London, London, UK.
  • Haque F; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Little N; University College London, London, UK.
  • McKechnie H; Imperial College London, London, UK.
  • Morris J; Avon & Wiltshire Mental Health Partnership NHS Trust, Bristol, UK.
  • Mosler F; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Mutz J; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Pauli R; Birmingham & Solihull Mental Health NHS Foundation Trust, Birmingham, UK.
  • Poovendran D; Imperial College London, London, UK.
  • Slater E; South Essex Partnership NHS Foundation Trust, Essex, UK.
  • Strang J; King's College London, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK; South London and Maudsley NHS Foundation Trust, London, UK.
Contemp Clin Trials ; 71: 124-132, 2018 08.
Article em En | MEDLINE | ID: mdl-29908336
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Reforço Psicológico / Terapia Comportamental / Buprenorfina / Dependência de Heroína / Serviços de Saúde Mental / Metadona / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Contemp Clin Trials Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Reforço Psicológico / Terapia Comportamental / Buprenorfina / Dependência de Heroína / Serviços de Saúde Mental / Metadona / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Contemp Clin Trials Ano de publicação: 2018 Tipo de documento: Article